Log In
BCIQ
Print this Print this
 

TP01

  Manage Alerts
Collapse Summary General Information
Company Zeria Pharmaceutical Co. Ltd.
DescriptionNot disclosed
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentRegistration
Standard IndicationIrritable bowel syndrome
Indication DetailsTreat irritable bowel syndrome (IBS)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today